Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001096906-24-002273
Filing Date
2024-12-17
Accepted
2024-12-17 12:22:18
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3471
  Complete submission text file 0001096906-24-002273.txt   5008
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Issuer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address C/O COMMUNITY REDEVELOPMENT, INC. 2650 BISCAYNE BLVD, 2ND FLOOR MIAMI FL 33137
Business Address
Kaplan Benjamin (Reporting) CIK: 0001850761 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56022 | Film No.: 241554334